Adebola Lawanson
Overview
Explore the profile of Adebola Lawanson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
24
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hamada Y, Quartagno M, Law I, Malik F, Bonsu F, Adetifa I, et al.
PLOS Glob Public Health
. 2024 Feb;
4(2):e0002596.
PMID: 38422092
Tuberculosis (TB) and non-communicable diseases (NCD) share predisposing risk factors. TB-associated NCD might cluster within households affected with TB requiring shared prevention and care strategies. We conducted an individual participant...
2.
Eneogu R, Mitchell E, Ogbudebe C, Aboki D, Anyebe V, Dimkpa C, et al.
PLOS Glob Public Health
. 2024 Jan;
4(1):e0002018.
PMID: 38232129
Wellness on Wheels (WoW) is a model of mobile systematic tuberculosis (TB) screening of high-risk populations combining digital chest radiography with computer-aided automated detection (CAD) and chronic cough screening to...
3.
Chijioke-Akaniro O, Onyemaechi S, Kuye J, Ubochioma E, Omoniyi A, Urhioke O, et al.
BMJ Open
. 2023 Sep;
13(9):e069123.
PMID: 37709312
Objectives: This study aimed to assess the practices of private practitioners regarding tuberculosis (TB), and to ascertain factors related to the low contribution of private healthcare providers to TB prevention...
4.
Hamada Y, Quartagno M, Law I, Malik F, Bonsu F, Adetifa I, et al.
EClinicalMedicine
. 2023 Sep;
63:102191.
PMID: 37680950
Background: Non-communicable diseases (NCDs) and NCD risk factors, such as smoking, increase the risk for tuberculosis (TB). Data are scarce on the risk of prevalent TB associated with these factors...
5.
Mulder C, Rupert S, Setiawan E, Mambetova E, Edo P, Sugiharto J, et al.
BMJ Glob Health
. 2022 Jan;
7(1).
PMID: 34992077
Introduction: Bedaquiline, pretomanid and linezolid (BPaL) is a new all oral, 6-month regimen comprised of bedaquiline, the new drug pretomanid and linezolid, endorsed by the WHO for use under operational...
6.
Gidado M, Nwokoye N, Ogbudebe C, Nsa B, Nwadike P, Ajiboye P, et al.
Niger Med J
. 2019 Aug;
60(1):33-39.
PMID: 31413433
Setting: Nigeria adopted GeneXpert MTB Rif as a primary diagnostic tool were available and accessible since 2016. The current geographical coverage of GeneXpert machines by LGAs stands at 48%, with...